Clinical Trial Execution, Live at OCT New England 2026
Stop Settling for “Real Time.” See What It Means to Go LIVE.
“Real-time” data often only becomes visible after site activity has been documented — when the opportunity to intervene may have already passed.
TruTechnologies is the industry’s first Live Clinical Trial Execution platform, combining dynamic protocol guidance with Live Data Capture™ to give sponsors source-level visibility as execution happens, while there is still time to act.
October 27–28 | Booth 68
Schedule Time with Tru at OCT New England 2026
We’d love to meet with you! Fill out the form and we’ll get back to you as soon as possible.
When “Real Time” Is Already Too Late: Lessons from Biomarker Operations
October 27 | 12:45 p.m. ET
Presented by Ayat Alsaraby, Associate Director, Biotech Relationship Management, TruTechnologies
- What “real time” looked like from the sponsor side when site activity became visible only after the work was complete
- How late queries and accessioning delays slowed data readout in a Phase I oncology study
- What changed when issues were identified and corrected before shipment
- Why clinical trial execution is foundational to better data and AI-ready trials
Ayat Alsaraby
Associate Director, Biotech Relationship Management
The New Standard in Clinical Trial Execution
The protocol defines the trial. Execution should follow it.
Tru brings dynamic protocol guidance and Live Data Capture™ to the point of care, helping sites execute protocol-required activities correctly while capturing source data as the work happens.
Because that data is captured live and in the context of execution, sponsors gain immediate visibility into site activity and sample status while there is still time to act. Teams can surface risks earlier, intervene sooner, and prevent avoidable issues before they escalate.
The result is a fundamentally different operating model: one built to prevent problems during execution instead of discovering them after the fact.
Proven Impact of Going Live
“Increased visibility internally is a key win. The ability to see what was or wasn’t collected in real time has been transformational.”
What Will You See at Booth 68?
See how Tru transforms protocol requirements into validated site workflows while capturing source-level data directly at the point of care.
Our team can show you how Tru supports:
- Dynamic, protocol-guided site workflows
- Live Data Capture™ at the point of care
- Biological sample collection, processing, and traceability
- Immediate sponsor visibility into site execution
- Earlier issue detection and intervention
- Less rework and burden for sponsors and sites
Bring us a current trial challenge or simply stop by to see what truly live clinical trial execution looks like.
Meet the Tru Team at OCT New England
Doug Blanchard
Account Executive, Biotech
Bryce Lugar
Director, Solutions Consulting
Ayat Alsaraby
Associate Director, Biotech Relationship Management
Jason Oberholtzer
Director, Business Development
Connect with our onsite team to discuss where delayed visibility may be creating risk across your trials and what becomes possible when execution goes live.
Clinical Trial Execution.
Live. Visible. Actionable.
OCT New England 2026 | October 27–28 | Booth 68